IVA logoIVA
Inventiva - ADR

483
Loading...
Loading...
Inventiva SA is a clinical-stage biopharmaceutical company, which focuses on the development of oral small molecule therapies for the treatment of non-alcoholic steatohepatitis, or NASH, and other diseases with significant unmet medical need. It owns an in-house drug-discovery platform that develops internal oncology and fibrosis discovery pipeline with approaches centered on transcription factors, epigenetics targets, and nuclear receptors. The company was founded by Pierre Broqua and Frédéric Cren on October 27, 2011 and is headquartered in Daix, France.
Sector:
Health Technology
Industry:
Biotechnology
Employees:
119

Frequently Asked Questions

What is Market Cap of Inventiva - ADR?
What is the 52-week high for Inventiva - ADR?
What is the 52-week low for Inventiva - ADR?
What is Inventiva - ADR stock price today?
What was Inventiva - ADR stock price yesterday?
What is the PE ratio of Inventiva - ADR?
What is the Price-to-Book ratio of Inventiva - ADR?
What is the 50-day moving average of Inventiva - ADR?
How many employess does Inventiva - ADR has?

Latest IVA News

View

Advertisement. Remove ads.

Advertisement. Remove ads.